A conserved oligomerization domain in the disordered linker of coronavirus nucleocapsid proteins
- PMID: 37018390
- PMCID: PMC10075959
- DOI: 10.1126/sciadv.adg6473
A conserved oligomerization domain in the disordered linker of coronavirus nucleocapsid proteins
Abstract
The nucleocapsid (N-)protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a key role in viral assembly and scaffolding of the viral RNA. It promotes liquid-liquid phase separation (LLPS), forming dense droplets that support the assembly of ribonucleoprotein particles with as-of-yet unknown macromolecular architecture. Combining biophysical experiments, molecular dynamics simulations, and analysis of the mutational landscape, we describe a heretofore unknown oligomerization site that contributes to LLPS, is required for the assembly of higher-order protein-nucleic acid complexes, and is coupled to large-scale conformational changes of N-protein upon nucleic acid binding. The self-association interface is located in a leucine-rich sequence of the intrinsically disordered linker between N-protein folded domains and formed by transient helices assembling into trimeric coiled-coils. Critical residues stabilizing hydrophobic and electrostatic interactions between adjacent helices are highly protected against mutations in viable SARS-CoV-2 genomes, and the oligomerization motif is conserved across related coronaviruses, thus presenting a target for antiviral therapeutics.
Figures
Similar articles
-
Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.Elife. 2024 Jun 28;13:RP94836. doi: 10.7554/eLife.94836. Elife. 2024. PMID: 38941236 Free PMC article.
-
SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.EMBO J. 2020 Dec 15;39(24):e106478. doi: 10.15252/embj.2020106478. Epub 2020 Dec 4. EMBO J. 2020. PMID: 33200826 Free PMC article.
-
Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid.Nucleic Acids Res. 2024 Jun 24;52(11):6647-6661. doi: 10.1093/nar/gkae256. Nucleic Acids Res. 2024. PMID: 38587193 Free PMC article.
-
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.Arch Med Res. 2020 Aug;51(6):482-491. doi: 10.1016/j.arcmed.2020.05.012. Epub 2020 May 25. Arch Med Res. 2020. PMID: 32493627 Free PMC article. Review.
-
The SARS coronavirus nucleocapsid protein--forms and functions.Antiviral Res. 2014 Mar;103:39-50. doi: 10.1016/j.antiviral.2013.12.009. Epub 2014 Jan 11. Antiviral Res. 2014. PMID: 24418573 Free PMC article. Review.
Cited by
-
A specific phosphorylation-dependent conformational switch in SARS-CoV-2 nucleocapsid protein inhibits RNA binding.Sci Adv. 2024 Aug 2;10(31):eaax2323. doi: 10.1126/sciadv.aax2323. Epub 2024 Aug 2. Sci Adv. 2024. PMID: 39093972 Free PMC article.
-
Unraveling the assembly mechanism of SADS-CoV virus nucleocapsid protein: insights from RNA binding, dimerization, and epitope diversity profiling.J Virol. 2024 Aug 20;98(8):e0092624. doi: 10.1128/jvi.00926-24. Epub 2024 Jul 31. J Virol. 2024. PMID: 39082816
-
Molecular Mechanisms and Potential Antiviral Strategies of Liquid-Liquid Phase Separation during Coronavirus Infection.Biomolecules. 2024 Jun 24;14(7):748. doi: 10.3390/biom14070748. Biomolecules. 2024. PMID: 39062463 Free PMC article. Review.
-
Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86.Microbiol Spectr. 2024 Jun 4;12(6):e0017924. doi: 10.1128/spectrum.00179-24. Epub 2024 Apr 22. Microbiol Spectr. 2024. PMID: 38647335 Free PMC article. No abstract available.
-
A narrow ratio of nucleic acid to SARS-CoV-2 N-protein enables phase separation.bioRxiv [Preprint]. 2024 Apr 11:2024.04.10.588883. doi: 10.1101/2024.04.10.588883. bioRxiv. 2024. Update in: J Biol Chem. 2024 Sep 27;300(11):107831. doi: 10.1016/j.jbc.2024.107831. PMID: 38645044 Free PMC article. Updated. Preprint.
References
-
- Q. Fernandes, V. P. Inchakalody, M. Merhi, S. Mestiri, N. Taib, D. Moustafa Abo El-Ella, T. Bedhiafi, A. Raza, L. Al-Zaidan, M. O. Mohsen, M. A. Y. Al-Nesf, A. A. Hssain, H. M. Yassine, M. F. Bachmann, S. Uddin, S. Dermime, Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 54, 524–540 (2022). - PMC - PubMed
-
- Y. Finkel, O. Mizrahi, A. Nachshon, S. Weingarten-Gabbay, D. Morgenstern, Y. Yahalom-Ronen, H. Tamir, H. Achdout, D. Stein, O. Israeli, A. Beth-Din, S. Melamed, S. Weiss, T. Israely, N. Paran, M. Schwartz, N. Stern-Ginossar, The coding capacity of SARS-CoV-2. Nature 589, 125–130 (2021). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous